Greenleaf Trust Sells 379 Shares of Agilent Technologies, Inc. (NYSE:A)

Greenleaf Trust lessened its holdings in Agilent Technologies, Inc. (NYSE:AGet Rating) by 4.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,319 shares of the medical research company’s stock after selling 379 shares during the period. Greenleaf Trust’s holdings in Agilent Technologies were worth $869,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Baker Avenue Asset Management LP grew its holdings in shares of Agilent Technologies by 0.3% during the second quarter. Baker Avenue Asset Management LP now owns 28,215 shares of the medical research company’s stock worth $3,351,000 after purchasing an additional 78 shares during the last quarter. CWM LLC lifted its stake in shares of Agilent Technologies by 1.7% in the second quarter. CWM LLC now owns 4,890 shares of the medical research company’s stock worth $581,000 after acquiring an additional 81 shares during the period. Massmutual Trust Co. FSB ADV lifted its stake in shares of Agilent Technologies by 1.6% in the second quarter. Massmutual Trust Co. FSB ADV now owns 5,332 shares of the medical research company’s stock worth $633,000 after acquiring an additional 83 shares during the period. Waldron Private Wealth LLC lifted its stake in shares of Agilent Technologies by 2.9% in the second quarter. Waldron Private Wealth LLC now owns 3,012 shares of the medical research company’s stock worth $357,000 after acquiring an additional 85 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in Agilent Technologies by 0.4% in the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 20,037 shares of the medical research company’s stock valued at $2,380,000 after buying an additional 89 shares during the period.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Jefferies Financial Group boosted their price target on Agilent Technologies from $158.00 to $168.00 in a research note on Tuesday. SVB Leerink upped their price target on Agilent Technologies from $145.00 to $160.00 and gave the stock an “outperform” rating in a report on Tuesday. KeyCorp upped their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Tuesday. Cowen upped their price target on Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday. Finally, Citigroup upped their price target on Agilent Technologies from $145.00 to $150.00 and gave the company a “neutral” rating in a research report on Tuesday. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $157.00.

Insider Buying and Selling at Agilent Technologies

In other news, VP Padraig Mcdonnell sold 2,103 shares of the stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total transaction of $258,437.67. Following the transaction, the vice president now directly owns 13,217 shares in the company, valued at approximately $1,624,237.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, VP Padraig Mcdonnell sold 2,103 shares of the firm’s stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total transaction of $258,437.67. Following the transaction, the vice president now directly owns 13,217 shares in the company, valued at approximately $1,624,237.13. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Michael Tang sold 3,600 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 1st. The stock was sold at an average price of $139.50, for a total value of $502,200.00. Following the completion of the sale, the senior vice president now owns 43,280 shares in the company, valued at $6,037,560. The disclosure for this sale can be found here. Insiders have sold a total of 174,326 shares of company stock valued at $26,474,537 in the last 90 days.

Agilent Technologies Stock Performance

Shares of A opened at $155.35 on Thursday. The stock’s 50-day simple moving average is $133.55 and its 200 day simple moving average is $128.29. Agilent Technologies, Inc. has a 52-week low of $112.52 and a 52-week high of $162.62. The stock has a market capitalization of $45.99 billion, a price-to-earnings ratio of 37.25, a price-to-earnings-growth ratio of 2.78 and a beta of 1.06. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.41 and a current ratio of 2.03.

Agilent Technologies (NYSE:AGet Rating) last released its quarterly earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.14. Agilent Technologies had a return on equity of 30.31% and a net margin of 18.31%. The firm had revenue of $1.85 billion for the quarter, compared to analysts’ expectations of $1.76 billion. During the same quarter last year, the firm posted $1.21 EPS. The company’s revenue was up 11.4% compared to the same quarter last year. Research analysts forecast that Agilent Technologies, Inc. will post 5.64 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Shareholders of record on Tuesday, January 3rd will be issued a $0.225 dividend. The ex-dividend date is Friday, December 30th. This represents a $0.90 annualized dividend and a dividend yield of 0.58%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.14%.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AGet Rating).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.